TAILORED PROTON PUMP INHIBITOR THERAPY, BASED ON ACID REFLUX PARAMETERS, IN LONG-SEGMENT BARRETT’S ESOPHAGUS PATIENTS: THE SIGNIFICANCE OF THE LEVEL OF SYMPTOM CONTROL.

(1) Gastrocentrum,Karolinska Universitetssjukhuset,Stockholm,Sweden

(2) Department of Clinical Epidemiology, Predictive Medicine and Public Health,Porto Medical School,Porto,Portugal

(3) Surgery,Ersta Hospital,Stockholm,Sweden

(4) Pathology,Klinic Bayreuth,Bayreuth,Germany

(5) CLINTEC,Karolinska Institutet,Stockholm,Sweden

(6) Department of Gastroenterology & Hepatology,Sahlgrenska University Hospital,Sahlgrenska Academy,Gothenburg,Sweden



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)